Previous Article | Next Article 
Journal of Virology, January 1999, p. 495-500, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Efficient Transduction by an Amphotropic Retrovirus
Vector Is Dependent on High-Level Expression of the Cell Surface
Virus Receptor
Peter
Kurre,1,2
Hans-Peter
Kiem,1,3
Julia
Morris,1
Scott
Heyward,1
Jean-Luc
Battini,1 and
A. Dusty
Miller1,4,*
Fred Hutchinson Cancer Research Center,
Seattle, Washington 98109,1 and
Departments of Pathology,4
Pediatrics,2 and
Medicine,3 University of Washington,
Seattle, Washington 98195
Received 7 August 1998/Accepted 25 September 1998
Transduction by murine leukemia virus-based retrovirus vectors is
limited in certain cell types, particularly in nondividing cells. But
transduction can be inefficient even in cells that divide rapidly. For
example, exposure of 208F rat embryo fibroblasts to an excess of an
amphotropic retrovirus vector encoding alkaline phosphatase results in
a transduction efficiency of only about 10%, even though these cells
divide rapidly. Here we show that transduction of 208F cells is limited
by cell surface retrovirus receptor levels; overexpression of the
amphotropic retrovirus receptor Pit2 markedly improved the transduction
efficiency to 50%. To characterize receptor levels and binding
affinity, we synthesized a fusion protein that joins the amino terminus
of the amphotropic envelope protein to the Fc region of a human
immunoglobulin G1 molecule for use in binding assays. In comparison to
the parental cell line, the modified cell line showed an order of
magnitude increase in binding sites of from 18,000 to 150,000 per cell. Thus, efficient transduction by an amphotropic retrovirus vector requires high-level expression of the retrovirus receptor Pit2. These
results provide the rationale for further examination of the role of
receptor levels in inefficient transduction, especially with regard to
target cells for gene therapy, where a high transduction rate is often crucial.
*
Corresponding author. Mailing address: Fred Hutchinson
Cancer Research Center, 1100 Fairview Ave. North, Room C2-023, Seattle, WA 98109-1024. Phone: (206) 667-2890. Fax: (206) 667-6523. E-mail: dmiller{at}fhcrc.org.
Journal of Virology, January 1999, p. 495-500, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rodenburg, M., Fischer, M., Engelmann, A., Harbers, S. O., Ziegler, M., Lohler, J., Stocking, C.
(2007). Importance of Receptor Usage, Fli1 Activation, and Mouse Strain for the Stem Cell Specificity of 10A1 Murine Leukemia Virus Leukemogenicity. J. Virol.
81: 732-742
[Abstract]
[Full Text]
-
Lucas, M. L., Seidel, N. E., Porada, C. D., Quigley, J. G., Anderson, S. M., Malech, H. L., Abkowitz, J. L., Zanjani, E. D., Bodine, D. M.
(2005). Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes. Blood
106: 51-58
[Abstract]
[Full Text]
-
Vigdorovich, V., Strong, R. K., Miller, A. D.
(2005). Expression and Characterization of a Soluble, Active Form of the Jaagsiekte Sheep Retrovirus Receptor, Hyal2. J. Virol.
79: 79-86
[Abstract]
[Full Text]
-
Kwon, Y. J., Hung, G., Anderson, W. F., Peng, C.-A., Yu, H.
(2003). Determination of Infectious Retrovirus Concentration from Colony-Forming Assay with Quantitative Analysis. J. Virol.
77: 5712-5720
[Abstract]
[Full Text]
-
Liu, S.-L., Duh, F.-M., Lerman, M. I., Miller, A. D.
(2003). Role of Virus Receptor Hyal2 in Oncogenic Transformation of Rodent Fibroblasts by Sheep Betaretrovirus Env Proteins. J. Virol.
77: 2850-2858
[Abstract]
[Full Text]
-
Jones, K. S., Nath, M., Petrow-Sadowski, C., Baines, A. C., Dambach, M., Huang, Y., Ruscetti, F. W.
(2002). Similar Regulation of Cell Surface Human T-Cell Leukemia Virus Type 1 (HTLV-1) Surface Binding Proteins in Cells Highly and Poorly Transduced by HTLV-1-Pseudotyped Virions. J. Virol.
76: 12723-12734
[Abstract]
[Full Text]
-
Tsai, E. J., Malech, H. L., Kirby, M. R., Hsu, A. P., Seidel, N. E., Porada, C. D., Zanjani, E. D., Bodine, D. M., Puck, J. M.
(2002). Retroviral transduction of IL2RG into CD34+ cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras. Blood
100: 72-79
[Abstract]
[Full Text]
-
Walker, S. J., Pizzato, M., Takeuchi, Y., Devereux, S.
(2002). Heparin Binds to Murine Leukemia Virus and Inhibits Env-Independent Attachment and Infection. J. Virol.
76: 6909-6918
[Abstract]
[Full Text]
-
Goerner, M., Horn, P. A., Peterson, L., Kurre, P., Storb, R., Rasko, J. E. J., Kiem, H.-P.
(2001). Sustained multilineage gene persistence and expression in dogs transplanted with CD34+ marrow cells transduced by RD114-pseudotype oncoretrovirus vectors. Blood
98: 2065-2070
[Abstract]
[Full Text]
-
Kelly, P. F., Vandergriff, J., Nathwani, A., Nienhuis, A. W., Vanin, E. F.
(2000). Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood
96: 1206-1214
[Abstract]
[Full Text]
-
Williams, D. A., Nienhuis, A. W., Hawley, R. G., Smith, F. O.
(2000). Gene Therapy 2000. ASH Education Book
2000: 376-393
[Abstract]
[Full Text]
-
Sena-Esteves, M., Saeki, Y., Camp, S. M., Chiocca, E. A., Breakefield, X. O.
(1999). Single-Step Conversion of Cells to Retrovirus Vector Producers with Herpes Simplex Virus-Epstein-Barr Virus Hybrid Amplicons. J. Virol.
73: 10426-10439
[Abstract]
[Full Text]
-
Battini, J.-L., Rasko, J. E. J., Miller, A. D.
(1999). A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: Possible role in G protein-coupled signal transduction. Proc. Natl. Acad. Sci. USA
96: 1385-1390
[Abstract]
[Full Text]